Table 1.
NRTI Name | Diffusion/SLC Transporter [Ref.] | Active ddNTP & ddNDP analogue | Plasma Half-Life [Ref.] | Inn a cellular half-life [Ref.] |
---|---|---|---|---|
Lamivudine (3TC) | OCT1, OCT2, CNT1 [24, 25, 27] | 3TC-TP | 22 h [26] | 15 to 16 h [29] |
Emtricitabine (FTC) | MATE1 [30] | FTC-TP | 37 h [31] | 39 h [31] |
Tenofovir Disoproxil Funiarate (TDF) | Direct diffusion [32] | TFV-DP | ∼17h [33] | 164 h [31] |
Tenofovir Alafenamide (TAF) | Direct diffusion [32] | TFV-DP | ∼125 h [33] | 164 h [31] |
Abacavir (ABC) | Direct diffusion [18] | CBV-TP | ∼3.3 [34]h | ∼18 to 21 h [35] |
Zidovudine (AZT) | OAT1-4, CNT1, CNT3, ENT2 | AZT-TP | ∼2 h [36] | ∼9 h [37] |
Didanosine (ddI) | CNT2, CNT3, ENT1, ENT2 [23, 38] | ddI-TP | 2.3 h [39] | 24 h to 40 h [40] |
Stavudine (d4T) | CNT1 [41] and. Direct diffusion [19] | d4T-TP | 7 h [42] | 4.5 h [43] |
CNT, concentrative nucleoside transporter; ENT, equilibrative nucleoside transporter; MATE, multidrug and toxin extrusion protein; OAT, organic anion transporter; OCT, organic cation transporter.